Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF6005/08
CompoundCebranopadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titleComparison of cebranopadol with placebo and with pregabalin
IndicationChronic Pain, DPN, Diabetic neuropathy
UTNU1111-1151-4331
CTG IDNCT01939366
CTIS ID (former EudraCT)2013-000473-68
Trial statusCompleted
FPISeptember 27, 2013
LPOJanuary 28, 2015
CountriesCzech Republic, Finland, Hungary, Poland, Romania, Russian Federation, United Kingdom
GenderAll
Age40 Years to 75 Years
ResultsYes
Pubmed
Documents
KF6005-08 | Grünenthal